Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nutritional High International Inc. Ordinary Shares SPLID

High Fusion Inc is engaged in the manufacturing, processing, and distribution of infused edible products. The company's operating and geographical segments include Palo Verde; Pasa Verde; Oregon; Colorado; Nevada and Washington. It generates maximum revenue from the Palo Verde segment.


OTCPK:SPLID - Post by User

Post by Greedeon Sep 26, 2018 2:01pm
84 Views
Post# 28694728

Good volume today at least

Good volume today at least

Sometimes, you gotta look for a silver lining when it seems there is none.

So what are the catalysts to that can get us back out of this low-priced funk (while the cannabis sector soars all around us?)

*Green Therapeutics will have to be the next near-term price mover.  Unless they surprise us with some other announcement, that seems to me the next event that will give us a little upward jolt into the $0.40s at least.

*Financials - whenever they come out (seems like it would be in November)  those should look VERY good versus our last November.  We should make some eyes pop because Calyx is re-shaping every aspect of this company's growth potential. 

Add the revenue of Green Therapeutics into our mix, we're looking like a $2m US per month company.  
 

In the not so distant future, we're going to look back at this price in amazement that in September of 2018, you could buy this stock for 30 cents a share.

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse